The FDA approval should open the minds to investors of the opportunities that companies like Virax have the potential to deliver an effective alternative treatment to treat these people affected by these illness`s,
If the phase ii trials for VIR-201 are effective,this will set a rocket underneath VHL`s shareprice,here is hoping.
GL all.